(Q52165423)

26 April 2018

title

Nimodipine improves the disruption of spatial cognition induced by cerebral ischemia. (English)

1 reference

26 April 2018

1 reference

Taya K

1

1 reference

26 April 2018

Watanabe Y

series ordinal

2

1 reference

26 April 2018

Kobayashi H

series ordinal

3

1 reference

26 April 2018

Fujiwara M

series ordinal

4

1 reference

26 April 2018

language of work or name

English

0 references

publication date

1 July 2000

1 reference

26 April 2018

published in

Physiology & Behavior

1 reference

26 April 2018

volume

70

1 reference

26 April 2018

issue

1-2

1 reference

26 April 2018

page(s)

19-25

1 reference

26 April 2018

Protection against blood-brain barrier disruption in focal cerebral ischemia by the type IV phosphodiesterase inhibitor BBB022: a quantitative study.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900221-3

7 January 2021

Nimodipine prevents early loss of hippocampal CA1 parvalbumin immunoreactivity after focal cerebral ischemia in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900221-3

7 January 2021

Failure of nimodipine to prevent brain damage in a global brain ischemia model in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900221-3

7 January 2021

Why do all drugs work in animals but none in stroke patients? 2. Neuroprotective therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900221-3

7 January 2021

The development of Ca2+ channel responses and their coupling to exocytosis in cultured cerebellar granule cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900221-3

7 January 2021

Relation between long-lasting amounts of excitatory amino acid and its neuronal uptake system in cultured cerebellar granule cells under hypoglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900221-3

7 January 2021

The effects of gamma 2-melanocyte-stimulating hormone and nimodipine on cortical blood flow and infarction volume in two rat models of middle cerebral artery occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900221-3

7 January 2021

The disruption of spatial cognition and changes in brain amino acid, monoamine and acetylcholine in rats with transient cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900221-3

7 January 2021

Characterization of zinc-induced neuronal death in primary cultures of rat cerebellar granule cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900221-3

7 January 2021

Potentiation of excito-toxicity by glutamate uptake inhibitor rather than glutamine synthetase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900221-3

7 January 2021

In vivo uptake of [3H]nimodipine in focal cerebral ischemia: modulation by hyperglycemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900221-3

7 January 2021

Effects of the dihydropyridine calcium channel blocker amlodipine on ventricular and atrial protein synthesis in an aortic constriction model of hypertension and, following chronic treatment, in the left ventricle of SHR rats

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900221-3

7 January 2021

A new model of bilateral hemispheric ischemia in the unanesthetized rat

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900221-3

7 January 2021

Neuronal protective effects of calcium antagonists in cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900221-3

7 January 2021

Reduction of infarct size by intra-arterial nimodipine administered at reperfusion in a rat model of partially reversible brain focal ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900221-3

7 January 2021

Relationships between ATP depletion, membrane potential, and the release of neurotransmitters in rat nerve terminals. An in vitro study under conditions that mimic anoxia, hypoglycemia, and ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900221-3

7 January 2021

Nimodipine prevents the in vivo decrease in hippocampal extracellular acetylcholine produced by hypobaric hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900221-3

7 January 2021

Effect of the calcium antagonist nimodipine on the delayed hypoperfusion following incomplete ischemia in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900221-3

7 January 2021

Arachidonate transport through the blood-retina and blood-brain barrier of the rat after reperfusion of varying duration following complete cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900221-3

7 January 2021

[Interaction between neurons and astrocytes involved in brain regulatory function as assessed by in vitro brain ischemia models]

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900221-3

7 January 2021

Medial frontal cortex lesions: deficits and treatment with nimodipine.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900221-3

7 January 2021

Antihypertensive effects of amlodipine, a new calcium antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900221-3

7 January 2021

Acidosis potentiates oxidative neuronal death by multiple mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900221-3

7 January 2021

The effect of nimodipine on post-ischemic cerebral glucose utilization and blood flow in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900221-3

7 January 2021

Comparative studies on the inhibitory effects of calcium antagonists on cytosolic Ca2+ levels increased by high-potassium or glutamate in cultured rat cerebellar granule cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900221-3

7 January 2021

10.1016/S0031-9384(00)00221-3

Identifiers

DOI

1 reference

26 April 2018

1 reference

26 April 2018